SPR-519

N/A

Report date: 2022/07/01 15:29:28
NME

Base Information

Drug NameSPR-519
Drug Alias NameSPR-519
ClassificationOther
Mechanisms of ActionPhosphatidylinositol 3 kinase alpha inhibitorsSerine/threonine-protein kinase mTOR inhibitors
TargetsSerine/threonine-protein kinase mTORPhosphatidylinositol 3 kinase alpha
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSphaera Pharma
China Registration ClassN/A

Develop Information

Active CompaniesSphaera Pharma
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A